Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back.
NICE International has helped to adapt 3 NICE guidelines and their associated quality indicators for use in the Cypriot healthcare system.
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.
Learn more about our independent advisory committees and how you can get involved.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
Independent committees develop and update our guidance. Join a NICE committee and use your voice to drive forward critical discussions - turning your personal experiences into guidance that benefits millions of people.
As a NICE committee member, you'll play a vital role in shaping our work. Your insights help equip health and care practitioners with the guidance they need to deliver best practice care.
On NICE’s 25th anniversary, our partners and collaborators in the health care system discuss what the future holds for NICE.
